Renal thrombotic microangiopathy induced by interferon-alpha.
Service de Nephrology, Hôpital Edouard Herriot, Lyon, France.
C
C
Badid
B
B
McGregor
J M
JM
Faivre
A
A
Guerard
L
L
Juillard
D
D
Fouque
M
M
Laville
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply* / Q000503:physiopathology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000139:chemically induced*; D012079:Renal Circulation
D000970:Antineoplastic Agents; D016898:Interferon-alpha